Abstract
Tetanus is a noncommunicable infectious disease of humans and certain animal species, acquired through environmental exposure. Clostridium tetani is an anaerobic, spore-forming resident of the soil as well as the intestinal tracts of a large proportion of animals and humans. The ubiquitous spores germinate to vegetative bacilli when introduced into the soft tissues of the host under conditions in which the partial pressure of molecular oxygen is low. The vegetative organisms produce a potent neurotoxin that acts on the central nervous system leading to the muscular contractions characteristic of the illness. Although a significant proportion of tetanus cases occur in wounded adults and children, the major burden of tetanus in the world is borne by neonates, who are both (1) contaminated at or soon after birth and (2) born to mothers who are not adequately immunized. Prevention of tetanus can be achieved by passive immunization following wounds in which presumptive contamination with spores occurred; however, a more efficient means of prevention is by active immunization with tetanus toxoid, which is chemically inactivated toxin.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abel, J. J., Firor W. M.,and Chalain, W., Researches on tetanus. Ix. Further evidence to show that tetanus toxin is not carried to central nervous system by way of the axis cylinders of motor nerves, Bull. Johns Hopkins Hosp. 63:373–402 (1938).
Adams, E. B., The prognosis and prevention of tetanus, S. Afr. Med. J. 42:739–743 (1968).
Alfery, D. D.,and Rauscher, L. A., Tetanus: A review, Crit. Care Med. 7:176–181 (1979).
Anonymous, Postoperative tetanus [editorial], Lancet 2:964–965 (1984).
Ball, K., Elford, J.,and Seaman, J., Tetanus and altitude [letter], Lancet 1: 801–802 (1987).
Band, J. D.,and Bennett, J. V., Tetanus, in: Infectious Diseases: A Modern treatise of Infectious Processes, 3rd ed. (P. D. Hoeprich, ed.), pp. 1107–1114, Harper & Row, New York, 1983.
Bandmann, F., Zum nachweis von tetanusbaccilen im darm von ulcus- und carcinomträgern, Z. Hyg. 136:559–567 (1953).
Banton, H. J.,and Miller, P. A., An observation of antitoxin titers after booster doses of tetanus toxoid, N. Engl. J. Med. 240:13–14 (1949).
Barile, M. F., Hardegree, M. C.,and Pittman, M., Immunization against neonatal tetanus in New Guinea. 3. The toxin-neutralization test and the response of guinea-pigs to the toxoids as used in the immunization schedules in New Guinea, Bull. Who 43:453–459 (1970).
Barkin, R. M., Samuelson, J. S.,and Gotlin, L. P., Dtp reactions and serologic response with a reduced dose schedule, J. Pediatr. 105:189–194 (1984).
Barkin, R. M., Pichichero, M. E., Samuelson, J. S.,and Barkin, S. Z., Pediatric diphtheria and tetanus toxoids vaccine: Clinical and immunologic response when administered as the primary series, J. Pediatr. 106:779–781 (1985).
Barr, M., Glenny, A. T.,and Butler, N. R., Immunization of babies with diphtheria-tetanus-pertussis prophylactic, Br. Med. J. 2:635–639 (1955).
Barrett, C. D., Timm, E. A., Molner, J. G., Timm, E. A.,and Weiss, C. F., Multiple antigen immunization of infants against poliomyelitis, diphtheria, pertussis and tetanus. Ii. Response of infants and young children to primary immunization and eighteen-month booster, Am. J. Public Health 49:644–655 (1959).
Barrett, C. D., Mcleon, I. W., Molner, J. G., Timm, E. A.,and Weiss, C. F., Multiple antigen immunization of infants against poliomyelitis, diphtheria, pertussis and tetanus. An evaluation of antibody responses of infants one day old to seven months of age at start of inoculations, Pediatrics 30:720–736 (1962).
Bauer, J. H.,and Meyer, K. F., Human intestinal carriers of tetanus spores in California, J. Infect. Dis. 38:295–305 (1926).
Behring, E. Von,and Kitasato, S., Ueber das Zustandekommen der Diphtherie-Immunität und Tetanus-Immunität bie Thieren, Dtsch. Med. Wochenschr. 16:1113–1114 (1890).
Berger, S. A., Cherubin, L. E., Nelson, S.,and Levine, L., Tetanus despite preexisting antitetanus antibody, J. Am. Med. Assoc. 240:769–770 (1978).
Berggren, G. G., Berggren, W., Verly, A., Garnier, N., Peterson, W., Ewbank, O.,and Dievdonne, W., Traditional midwives, tetanus immunization, and infant mortality in rural Haiti, Trop. Doct. 13:79–87 (1983).
Bernath, S.,and Habermann, E., Solid-phase radioimmunoassay in antibody coated tubes for the quantitative determination of tetanus antibodies, Med. Microbiol. Immunol. 160:47–51 (1974).
Bernbaum, J. C., Daft, A., Anolik, R., Samuelson, J., Barkin, R., Douglas, S.,and Polin, R., Response of preterm infants to diphtheria-tetanus-pertussis immunizations, J. Pediatr. 107:184–188 (1985).
Bhat, G. J., Joshi, M. K.,and Kandoth, P. W., Neonatal tetanus: A clinical study of 100 cases, Indian Pediatr. 16:159–166 (1979).
Bhatt, A. D.,and Dastur, F. D., Relapsing tetanus: A case report, J. Postgrad. Med. 27:184–186 (1981).
Bizzini, B., Tetanus toxin, Microbiol. Rev. 43:224–240 (1979).
Bizzini, B., Tetanus, in: Bacterial Vaccines (R. Germanier, ed.), pp. 38–68, Academic Press, New York, 1984.
Bizzini, B., The chemistry of tetanus toxin as a basis for understanding its immunological and biological activities, in: Seventh International Conference on Tetanus (G. Nistico, P. Mastroeni, and M. Pitzurra, eds.), pp. 11–28, Gangeni, Rome, 1985.
Blake, P. A.,and Feldman, R. A., Tetanus in the United States 1970–1971, J. Infect. Dis. 131:745–748 (1975).
Bleck, T. P., Pharmacology of tetanus, Clin. Neuropharmacol. 9:103–120 (1986).
Boyd, R. E., Brennan, P. T., Denj, J.-F., Rochester, D. F.,and Spyker, D. A., Strychnine poisoning, Am. J. Med. 74:507–512 (1983).
Brand, D. A., Acampora, D., Gottlieg, L., Glancy, K. E.,and Frazier, W. H., Adequacy of antitetanus prophylaxis in six hospital emergency rooms, N. Engl. J. Med. 309:636–640 (1983).
Brooks, V. B.,and Asanuma, H., Action of tetanus toxin in the cerebral cortex, Science 137:674–676 (1962).
Brooks, V. B., Curtis, D. R.,and Eccles, J. C., Mode of action of tetanus toxin, Nature 175:120–121 (1955).
Brown, G. C., Volk, V. K., Gottshall, R. Y., Kendrick, P. L.,and Anderson, H. D., Responses of infants to Dtp P vaccine used in nine injection schedules, Public Health Rep. 79:585–602 (1964).
Bruce, D., Tetanus, J. Hyg. 19:1–32 (1920).
Buchanan, N., Cane, G. W.,and Deandrade, M., Autonomic dysfunction in tetanus: The effects of a variety of therapeutic agents, with special reference to morphine, Intensive Care Med. 5:65–68 (1979).
Buchanan, T. M., Brooks, G. F., Martin, S.,and Bennett, J. V., Tetanus in the United States, 1968 and 1969, J. Infect. Dis. 122:564–567 (1970).
Bulloch, W. E.,and Cramer, W., On a new factor in the mechanism of bacterial infection, Proc. R. Soc. London Ser. B 90:513–528 (1919).
Bytchenko, B., Geographical distribution of tetanus in the world, 1951–60, Bull. Who 34:71–104 (1966).
Bytchenko, B., Microbiology of tetanus, in: Tetanus: Important New Concepts (R. Veronesi, ed.), pp. 28–39, Excerpta Medica, Amsterdam, 1981.
Bytchenko, B., Current status of tetanus in the European region in: Eighth International Conference on Telanus (G. Nistico, B. Bizzini, B. Bytchenko,and R. Triau, eds.), Pythagora Press, Rome (in press).
Bytchenko, B. D., Causse, G., Grab, B.,and Kereselidze, T. S., Tetanus: Recent trends of world distribution, in: Sixth International Conference on Tetanus (C. Merieux, ed.), pp. 97–111, Collection Foundation Merieux, Lyon, 1981.
Cain, H. D.,and Falco, F. G., Recurrent tetanus, Calif. Med. 97:31–33 (1962).
Carle,and Rattone, Studio spetrimentale sull’ etiologia del tetano, G. Accad. Med. Torino 32:174 (1884).
Centers for Disease Control, Safety of theraputic immune globulin preparations with respect to transmission of human T lymphocytic virus type III/lymphadenopathy-associated virus infection, Morbid. Mortal. Weekly Rep. 35:231–233 (1986).
Chen, S. T., Edsall, G., P. M. M.,and Sinnathuray, T. A., Timing of antenatal tetanus immunization for effective protection of the neonate, Bull. Who 61:159–163 (1983).
Cherubin, C. E., Epidemiology of tetanus in narcotic addicts, N.Y. State J. Med. 70:267–271 (1970).
Christiansen, G., Quantification of tetanus antitoxin by toxin neutralization test in mice. A comparison between lethal and paralytic techniques, J. Biol. Stand. 9:453–460 (1981).
Cliff, J., Neonatal tetanus in Maputo, Mozambique. Part I: Hospital incidence and childbirth practices, Cent. Afr. J. Med. 31:9–12 (1985).
Coleman, G. E.,and Meyer, K. F., Study of tetanus agglutinins and antitoxin in human serums, J. Infect. Dis. 39:332–336 (1926).
Collier, L. H., Polakoff, S.,and Mortimer, J., Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines, Lancet 1: 1364–1368 (1979).
Committee on Infectious Diseases, American Academy of Pediatrics, Report of the Committee on Infectious Diseases (G. Peter, C. B. Hall, M. L. Lepow,and C. F. Phillips, eds.), American Academy of Pediatrics, Elk Grove Village, Ill. 1988.
Committee on Trauma, American College of Surgeons, Prophylaxis against tetanus in wound management, Am. Coll. Surg. Bull. 69:22–23 (1984).
Cooke, J. V., Holowach, J., Atkins, J. E.,and Powens, J. R., Antibody formation in early infancy against diphtheria and tetanus toxoids, J. Pediatr. 33:141–146 (1948).
Coursaget, P., Yvonnet, B., Relyveld, E. H.,and Barnes, J. L., Simultaneous administration of diphtheria/ tetanus/pertussis/polio vaccine and hepatitis B vaccine in a simplified immunization programme, Dev. Biol. Stand. 65:169–175 (1986).
Cox, J. C., Permier, R. R., Finger, W.,and Hurrell, J. G., A comparison of enzyme immunoassay and bioassay for the quantitative determination of antibodies to tetanus toxin, J. Biol. Stand. 11:123–128 (1983).
Crossley, K., Irvine, P., Warren, B., Lee, B. K.,and Mead, K., Tetanus and diphtheria immunity in urban Minnesota adults, J. Am. Med. Assoc. 242:2298–2300 (1979).
Dastur, D. D., Awatramani, V. P.,and Dixit, S. K., Response to single dose of tetanus vaccine in subjects with naturally acquired tetanus antitoxin, Lancet 2:219–222 (1981).
Descombey, P., L’anatoxine tetanique, Can. R. Soc. Biol. 91:239–241 (1924).
Dhillon, H.,and Menon, P. S., Active immunization of women in pregnancy with two injections of absorbed tetanus toxoid for prevention of tetanus neonaturum in Punjab, India, Indian J. Med. Res. 63:583–589 (1975). 589 (1975).
Di Sant Agnese, P. A., Combined immunization against diphtheria, tetanus, and pertussis in newborn infants. I. Production of antibodies in early infancy, Pediatrics 3:20–33 (1949).
Di Sant Agnese, P. A., Combined immunization against diphtheria, tetanus, and pertussis in newborn infants. Ii. Duration of antibody levels. Antibody titers after booster dose. Effect of passive immunity to diphtheria on active immunization with diphtheria toxoid, Pediatrics 3:181–194 (1949).
Di Sant Agnese, P. A., Combined immunization against diphtheria, tetanus, and pertussis in newborn infants. III. Relationship of age to antibody production, Pediatrics 3:333–344 (1949).
Di Sant Agnese, P. A., Simultaneous immunization of newborn infants against diphtheria, tetanus, and pertussis. Production of antibodies and duration of antibody levels in an eastern metropolitan area, Am. J. Public Health 40:674–680 (1950).
Edmondson, R. S.,and Flowers, M. W., Intensive care in tetanus: Management, complications and mortality in 100 cases, Br. Med. J. 1:1401–1404 (1979).
Edsall, G., The inexcusable disease, J. Am. Med. Assoc. 235:62–63 (1976).
Edsall, G., Problems in the immunology and control of tetanus, Med. J. Aust. 2:216–220 (1976).
Edsall, G., Elliot, M. W., Peebles, T. C.,and Eloned, M. C., Excessive use of tetanus toxoid boosters, J. Am. Med. Assoc. 202:17–19 (1967).
Einhorn, M. S., Granoff, D. M., Nahm, M. H., Quinn, A.,and Shackelford, P. G., Concentrations of antibodies in paired maternal and infant sera: Relationship to IgG subclass, J. Pediatr. 111:783–788 (1987).
Expanded Programme on Immunization, Global Advisory Group, Weekly Epidemiol. Rec. 60:13–16 (1985).
Expanded Programme on Immunization, Information System, Who/Epi/Gen/89.2, July 1989, p. 1.
Expanded Programme on Immunization, Epi Update. Neonatal Tetanus: The Invisible Killer, Who, September 1986.
Expanded Programme on Immunization, Issues in Neonatal Tetanus Control, Epi/Gag/87/Wp. 11, Who, 1987.
Facktor, M. A., Bernstein, R. A.,and Fireman, P., Hypersensitivity to tetanus toxoid, J. Allergy Clin. Immunol. 52:1–12 (1973).
Fedinec, A. A., Current studies on pathogenesis of tetanus, in: Seventh International Conference on Tetanus (G. Nistico, P. Mastroeni, and M. Pitzurra, eds.), pp. 61–68, Rome, 1985.
Finn, L. W., Jr., Silver, R. P., Habig, W. H., and Handegnee, M. C., The structural gene for tetanus neurotoxin is on a plasmid, Science 224:881–884 (1984).
Friedemann, U., Zuger, B., and Hollander, A., Investigations on the pathogenesis of tetanus, J. Immunol. 36:473–488 (1939).
Gaisford, W. Feloman, G. V., and Penkins, F. T., Current immunization problems, J. Pediatr. 56:319–330 (1960).
Galazka, A., Gasse, F., and Henderson, R. H., Neonatal tetanus in the world and the global Expanded Programme on Immunization, in: Eighth International Conference on Tetanus (G. Nistico, B. Bizzini, B. Bytchenko, and R. Triau, eds.), Pythagora Press, Rome (in press).
Garcia-Palmieri, M. R., and Ramirez, R., Generalized tetanus: Analysis of 202 cases, Ann. Intern. Med. 47:721–730 (1957).
Garnier, M. J., Tetanus in patients 3 years of age and up, Am. J. Surg. 129:459–463 (1975).
Giangrosso, J., and Smith, R. K., Misuse of tetanus immunoprophylaxis in wound care, Ann. Emerg. Med. 14:573–579 (1985).
Gill, D. M., Bacterial toxins: A table of lethal amount, Microbiol. Rev. 46:86–94 (1982).
Gottlieb, S., Mclaughlin, F. X., Levine, L., Latham, W. C., and Edsall, G., Long-term immunity to tetanus: A statistical evaluation and its clinical implications, Am. J. Public Health 54:961–971 (1964).
Green, J., Erdmann, J. G., and Wellhover, H. H., Is there retrograde axonal transport of tetanus toxin in both alpha and gamma fibres? Nature 265:370 (1977).
Gupta, R. K., Maheshwari, S. C., and Singh, H., The titration of tetanus antitoxin. I. Factors affecting the sensitivity of the indirect haemagglutination test, J. Biol. Stand 12:11–17 (1984).
Gupta, R. K., Maheshwari, S. C., and Singh, H., The titration of tetanus antitoxin. II. A comparative evaluation of the indirect haemagglutination and toxin neutralization tests, J. Biol. Stand. 12:137–143 (1984).
Halsey, N. A., and Galazka, A., The efficacy of Dpt and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age, Bull. Who 63:1151–1169 (1985).
Hamid, E. D., Daulay, A. P., Lubis, C. P., Rusdidjas, and Siregar, H., Tetanus neonatorum in babies delivered by traditional birth attendants in Medan, Indonesia, Pediatr. Indones. 25:167–174 (1985).
Hardegree, M. C., Barre, M. F., Pittman, M., Mal-Oney, C. J., Schofield, F., and Maclennan, R., Immunization against neonatal tetanus in New Guinea. 4. Cornparison of tetanus antitoxin titers obtained by haemagglutination and toxin neutralization in mice, Bull. Who 43:461–468 (1970).
Heath, C. W., Zusman, J., and Sherman, I. L., Tetanus in the United States, 1950–1960, Am. J. Public Health 54:769–779 (1964).
Hernandez, R., Just, M., and Burgin-Wolf, A., Immunoglobulin classes of human antitoxin after tetanus vaccination studies by immunofluorescence with agarose bound tetanus toxoid, Z. Immunol. Forsch. 145:376–384 (1973).
Hinman, A. R., Foster, S. O., and Wassilak, S. G. F., Neonatal tetanus: Potential for elimination in the Usa and the world, Pediatr. Infect. Dis. J. 6:813–816 (1987).
Holden, J. M., and Strang, D. U., Reactions to tetanus toxoid: Comparison of fluid and adsorbed toxoids, N. Z. Med. J. 64:574–577 (1965).
Holliday, P. L., and Bauer, R. B., Polyradiculoneuritis secondary to immunization with tetanus and diphtheria toxoids, Arch. Neurol. 40:56–57 (1983).
Hollow, V. M., and Clarke, G. M., Autonomic manifestations of tetanus, Anaesth. Intensive Care 3:142–147 (1975).
Humbert, G., Fillastre, J. P., Dordain, M., Leroy, J., Robert, M., and Delaunay, P., One hundred cases of tetanus, Scand. J. Infect. Dis. 4:129–131 (1972).
Immunization Practices Advisory Committee (Acip), Diphtheria, tetanus and pertussis. Guidelines for vaccine prophylaxis and other preventive measures, Morbid. Mortal. Weekly Rep. 34:405–414, 419–426 (1985).
Immunization Practices Advisory Committee (Acip), New recommended schedule for active immunization of normal infants and children, Morbid. Mortal. Weekly Rep. 35:577–579 (1986).
Jacobs, R. L., Lowe, R. S., and Lanier, B. Q., Adverse reactions to tetanus toxoid, J. Am. Med. Assoc. 247:40–42 (1982).
Jagetiya, P., and Bhandari, B., Analysis of tetanus neonatorum cases admitted in a hospital during 1976–1977, Indian J. Public Health 23:103–105 (1979).
Jones, A. E., Melville-Smith, M., Watkins, J., Seagroatt, V., Rice, L., and Sheffield, F., Adverse reactions in adolescents to reinforcing doses of plain and adsorbed tetanus vaccines, Community Med. 7:99–106 (1985).
Jones, F. G., and Moss, J. M., Studies on tetanus toxoid. I: The antitoxic titer of human subject following immunization with tetanus toxoid and tetanus alum precipitated toxoid, J. Immunol. 30:115–125 (1936).
Kaiser, G. C., King, R. D., Lempe, R. E., and Ruster, M. H., Delayed recall of active tetanus immunization, J. Am. Med. Assoc. 178:914–916 (1961).
Kanarek, D. J., Kaufman, B., and Zwi, S., Severe sympathetic hyperactivity associated with tetanus, Arch. Intern. Med. 132:602–604 (1973).
Kerr, J. H., Corbett, J. L., Prys-Roberts, C., Smith, A. C., and Spalding, J. M., Involvement of the sympathetic nervous system in tetanus: Studies on 82 cases, Lancet 2:236–241 (1968).
Kerrin, J. C., The incidence of B. tetani in human feces, Br. J. Pathol. 9:69–71 (1928).
Kessel, E., Strategies for the control of neonatal tetanus, J. Trop. Pediatr. 30:145–149 (1984).
Kielmam, A. A., and Vohra, S. R., Control of tetanus neonatorum in rural communities-Immunization effects of high-dose calcium phosphate-adsorbed tetanus toxoid, Indian J. Med. Res. 66:906–916 (1977).
Kircher, T., and Anderson, R. E., Cause of death: Proper completion of the death certificate, J. Am. Med. Assoc. 77:137–139 (1987).
Kishimoto, S., Tomino, S., Mitsuya, H., Fujiwara, H., and Tsuda, H., Age-related decline in the in vitro and in vivo syntheses of anti-tetanus toxoid antibody in humans, J. Immunol. 125:2347–2352 (1980).
Kitasato, S., Ueber den tetanusbacillus, Z. Hyg. 7:225–234 (1889).
Koblin, B. A., and Townsend, T. R., Immunity to diphtheria and tetanus in inner-city women of childbearing age, Am. J. Public Health 79:1297–1298 (1989).
Kryzhanovsky, G. N., Pathophysiology, in: Tetanus: Important New Concepts (R. Veronesi, ed.), pp. 109–182, Excerpta Medica, Amsterdam, 1981.
Laird, W. J., Aaronson, W., Silver, R. P., Habig, W. H., and Hardegree, M. C., Plasmid-associated toxigenicity in Clostridium tetani, J. Infect. Dis. 142:623 (1980).
Layton, G. T., A micro-enzyme-linked immunosorbent assay (Elisa) and radioimmunosorbent technique (Rist) for the detection of immunity to clinical tetanus, Med. Lab. Sci. 37:323–329 (1980).
Levine, L., and Edsall, G., Tetanus toxoid: What determines reaction proneness? J. Infect. Dis. 144:376 (1981).
Levine, L., Mccomb, J. A., Dwyer, R. C., and Latham, W. C. Active-passive tetanus immunization, N. Engl. J. Med. 274:186–190 (1966).
Levinson, A. K., Marske, R. L., and Shein, M. K., Tetanus in heroin addicts, J. Am. Med. Assoc. 157:658–660 (1955).
Long, A. P., and Sartwell, P. E., Tetanus in the U.S. Army in World War II, Bull. U.S. Army Med. Dep. 7:371–385 (1947).
Lowbury, E. J. L., and Lilly, H. A., Contamination of operating-theatre air with Cl. tetani, Br. Med. J. 2:1334–1336 (1958).
Lowbury, E. J. L., Kidson, A., Lilly, H. A., Wilkins, M. D., and Jackson, O. M., Prophylaxis against tetanus in non-immune patients with wounds: The role of antibiotics and of human antitetanus globulin, J. Hyg. 80:267–274. (1978).
Macko, M. B., Comparison of the morbidity of tetanus toxoid boosters with tetanus-diphtheria toxoid boosters, Ann. Emerg. Med. 14:33–35 (1985).
Maclennan, R., Schofield, F. D., Pittman, M., Hardegree, M. C., and Banile, M. F., Immunization against neonatal tetanus in New Guinea: Antitoxin response of pregnant women to adjuvant and plain toxoids, Bull. Who 32:683–697 (1965).
Mahoney, L. J., Aprile, M. A., and Moloney, P. J., Combined active-passive immunization against tetanus in man, Can. Med. Assoc. J. 96:1401–1404 (1967).
Marconi, P., Pitzurra, M., and Bistoni, F., Passive hemagglutination as the reference method for evaluation of tetanus immunity, in: Seventh International Conference on Tetanus (G. Nistico, P. Mastroeni, and M. Pitzurra, eds.), pp. 259–273, Gangeni, Rome, 1985.
Matsuda, M., and Yoneda, M., Isolation and purification of two antigenically active, “complementary” polypeptide fragments of tetanus neurotoxin, Infect. Immun. 12:1147–1153 (1975).
Matzkin, H., and Rege V, S., Naturally acquired immunity to tetanus toxin in an isolated community, Infect. Immun. 48:267–268 (1985).
McComb, J. A., The prophylactic dose of homologous tetanus antitoxin, N. Engl. J. Med. 270:175–178 (1964).
McComb, J. A., and Levine, L., Adult immunization. II. Dosage reduction as a solution to increasing reactions to tetanus toxoid, N. Engl. J. Med. 265:1152–1153 (1961).
Melville-Smith, M. E., Seagroatt, V. A., and Watkins, J. T., A comparison of enzyme-linked immunosorbent assay (Elisa) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera, J. Biol. Stand. 11:137–144 (1983).
Millard, A. H., Local tetanus, Lancet 2:844–846 (1954).
Moynihan, N. H., Serum sickness and local reactions in tetanus prophylaxis: A study of 400 cases, Br. Med. J. 2:264–266 (1955).
Myers, M. G., Beckman, C. W., Vosdingh, R. A., and Hankin, S., Primary immunization with tetanus and diphtheria toxoids. Reaction rate and immunogenicity in older children and adults, J. Am. Med. Assoc. 248:2478–2480 (1982).
Newell, K. W., Duenas Lehman, A., Leblanc, D. R., and Garces Osorio, N., The use of toxoid for the prevention of tetanus neonatorum. Final report of a double-blind controlled field trial, Bull. Who 35:863–871 (1966).
Nicolaier, A., Ueber infectiosen tetanus, Dtsch. Med. Wochenschr. 10:842–844 (1884).
Orenstein, W. A., Weisfeld, J. S., and Halsey, N. A., Diphtheria and tetanus toxoids and pertussis vaccine, combined, in: Recent Advances in Immunization: A Bibliographic Review, Paho Scientific Publ. 451, 1983, pp. 30–51.
Ourth, D. D., and Macdonald, A. B., Neutralization of tetanus toxin by human and rabbit immunoglobulin classes and subunits, Immunology 3:807–815 (1977).
Ourth, D. D., Murray, E. S., Macdonald, A. B., and Spielman, J. M., An indirect immunofluorescent test for human antibodies to tetanus toxoid using an insoluble toxoid as antigen, J. Clin. Exp. Immunol. 19:571–577 (1975).
Passen, E. L., and Andersen, B. R., Clinical tetanus despite a ‘protective’ level of toxin-neutralizing antibody, J. Am. Med. Assoc. 255:1171–1173 (1986).
Patel, J. C., Mehta, B. C., and Modi, K. N., Prognosis in tetanus, in: Proceedings of the International Conference on Tetanus, 1963 (J. C. Patel, ed.), p. 181, Ph Ramans, Bombay, 1965.
Peebles, T. C., Levine, L., Eldred, M. L., Edsall, G., Tetanus-toxoid emergency boosters: A reappraisal, N. Engl. J. Med. 280:575–581 (1969).
Peel, M. M., Measurement of tetanus antitoxin. I. Indirect haemagglutination, J. Biol. Stand. 8:177–189 (1980).
Peterson, J. C., and Christie, A., Immunization in the young infant: Response to combined vaccines. Vi. Tetanus, Am. J. Dis. Child. 81:518–529 (1951).
Pichichero, M. E.,Barkin, R. M., and Samuelson, J. S., Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: Immune response to the first booster following the diphtheria and tetanus toxoids primary series, Pediatr. Infect. Dis. J. 5:428–430 (1986).
Pitzurra, L. F., Bistoni, M., Pitzurra, L., Bastianini, L., Piento, S., Vecchiarelli, A., and Marconi, P., Comparison of passive haemagglutination with turkey erythrocyte assay, enzyme-linked immunosorbent assay and counter immunoelectrophoresis assay for serological evaluation of tetanus immunity, J. Clin. Microbiol. 17:432–435 (1983).
Pratt, E. L., Clinical tetanus: A study of fifty-six cases with special reference to methods of prevention and a plan for evaluating treatment, J. Am. Med. Assoc. 129:1243–1247 (1945).
Price, D. L., Griffin, J. W., Young, A., Peck, K., and Stock, A., Tetanus toxin: Direct evidence for retrograde axonal transport, Science 188:945–957 (1975).
Ray, S. N., Ray, K., and Grover, S. S., Sero-survey of diphtheria and tetanus antitoxin, Indian J. Med. Res. 68:901–904 (1978).
Rey, M., and Thikhomirov, E., Non-neonatal tetanus over the world, in: Eighth International Conference on Tetanus (G. Nistico, B. Bizzini, B. Bytchenko, and R. Triau, eds.), Pythagora Press, Rome (in press).
Robinson, J. P., and Hash, J. H., A review of the molecular structure of tetanus toxin, Mol. Cell. Biochem. 48:33–44 (1982).
Roistacher, K., and Griffin, J. W., Local tetanus, Johns Hopkins Med. J. 149:84–88 (1981).
Rosenbach, Zur aetiologie des wundstarrkrampfes beim menschen, Arch. Klin. Chir. 34:306–317 (1886).
Ruben, F. L., Nagel, J., and Fireman, P., Antitoxin responses in the elderly to tetanus-diphtheria (Td) immunization, Am. J. Epidemiol. 108:145–149 (1978).
Rutledge, S. L., and Snead, O. C., Neurologic complications of immunizations, J. Pediatr. 109:917–923 (1986).
Salimpour, R., Cause of death in tetanus neonatorum: Study of 233 cases with 54 necropsies, Arch. Dis. Child. 52:587–594 (1977).
Scheibel, I., Bentzon, M. W., Christensen, P. E., and Biering, A., Duration of immunity to diphtheria and tetanus after active immunization, Acta Pathol. Microbiol. Scand. 67:380–392 (1966).
Schwab, M. E., and Thoenen, H., Selective binding, uptake and retrograde transport of tetanus toxin by nerve terminals in the rat iris, J. Cell Biol. 77:1–13 (1978).
Sedgwick, A. K., Ballow, M., Sparks, K., and Tilton, R. C., Rapid quantitative micro-enzyme-linked immunosorbent assay for tetanus antibodies, J. Clin. Microbiol. 18:104–109 (1983).
Simonsen, O., Kjeldsen, K., and Heron, I., Immunity against tetanus and effect of revaccination 25–30 years after primary vaccination, Lancet 2:1240–1242 (1984).
Sisk, C. W., and Lewis, C. E., Reactions to tetanus-diphtheria toxoid (adult), Arch. Environ. Health 11:34–36 (1965).
Smith, J. W. G., Diphtheria and tetanus toxoids, Br. Med. Bull 25:177–182 (1969).
Smith, J. W. G., Tetanus and its prevention, Prog. Drug Res. 19: 391–401 (1975).
Smith, J. W. G., Tetanus, in: Topley and Wilson’s Principles of Bacteriology, Virology and Immunity, Volume 3 (G. Wilson, A. Miles, and M. T. Parker, eds.), pp. 345–368, Williams & Wilkins, Baltimore, 1984.
Smith, J. W. G., and Maciver, A. G., Studies in experimental tetanus infection, J. Med. Microbiol. 2:385–393 (1969).
Smith, J. W. G., Laurence, D. R., and Evans, D. G., Prevention of tetanus in the wounded, Br. Med. J. 3:453–455 (1975).
Smith, R. E., and Wolnisty, C., Allergic reactions to tetanus, diphtheria, influenza and poliomyelitis immunization, Ann. Allergy 20:809–813 (1962).
Smith, W. D., and Tobias, M. A., Tetany, tetanus or drug reaction? Br. J. Anaesth. 48:703–705 (1976).
Solomonova, K., and Vizev, S., Secondary response to boostering by purified aluminum-hydroxide-adsorbed tetanus antitoxin in aging and in aged adults, Immunobiology 158:312–319 (1981).
Spenney, J. G., Lamb, R. N., and Cobbs, C. G., Recurrent tetanus, South. Med. J. 64:859–862 (1971).
Stanfield, J. P., and Galazka, A., Neonatal tetanus in the world today, Bull. Who 62:647–669 (1984).
Suleman, O., Mortality from tetanus neonatorum in Punjab (Pakistan), Pak. Pediatr. J. 6:152–183 (1982).
Sum, J. C., and Rubbo, S. D., Immunization against tetanus, J. Hyg. 59:29–48 (1961).
Sutter, R. W., Cochi, S. L., Brink, E. W., and Sirotkin, B. I., Assessment of vital statistics and surveillance data for monitoring tetanus mortality, 1979–1984 Am. J. Epidemiol. 131:132–142 (1990).
Tenbroeck, C., and Bauer, J. H., The tetanus bacillus as an intestinal saprophyte in man, J. Exp. Med. 36:261–271 (1922).
Tenbroeck, C., and Bauer, J. H., Studies on the relation of tetanus bacilli in the digestive tract to tetanus antitoxin in the blood, J. Exp. Med. 37:479–489 (1923).
Traverso, H. D., Bennet, J. V., Kahn, A. J., Aghan, S. B., Rahim, H., Kamil, S., and Lang, M. H., Ghee application to the umbilical cord: A risk factor for tetanus, Lancet 1:486–488 (1989).
Trujillo, M. J., Castillo, A., Espana, J. V., Guevana, P., and Eganez, H., Tetanus in the adult: Intensive care and management experience with 233 cases, Crit. Care Med. 8:419–423 (1980).
Trujillo, M. H., Castillo, A., Espana, J., Manzo, A., and Zerpa, R., Impact of intensive care management on the prognosis of tetanus. Analysis of 641 cases, Chest 92:63–65 (1987).
Tulloch, W. J., Report of bacteriological investigation of tetanus carried out on behalf of the war office committee for the study of tetanus, J. Hyg. 18:103–202 (1919).
Turner, T. B., Velasco-Joven, E. A., and Prudovsky, S., Studies on the prophylaxis and treatment of tetanus. II. Studies pertaining to treatment, Bull. Johns Hopkins Hosp. 102:71–84 (1958).
Ullberg-Olsson, K., Vaccinationsreaktioner efter injektion: av tetanustoxoid med och utan tillsats av difteritoxoid, Lakartidningen 76:2976 (1979).
Van Heyningen, S., Tetanus toxin, Pharmacol. Ther. 11:141–157 (1980).
Vassilev, T. L., Aluminum phosphate but not calcium phosphate stimulates the specific IgE response in guinea-pigs to tetanus toxoid, Allergy 33:155–159 (1978).
Veronesi, R., Naturally acquired tetanus immunity: Still a controversial theme? in: Seventh International Conference on Tetanus (G. Nistico, P. Mastroeni, and M. Pitzurra, eds.), Gangeni, Rome, 1985, pp 365–372.
Veronesi, R., and Focaccia, R., The clinical picture, in: Tetanus: Important New Concepts (R. Veronesi, ed.), pp. 459–463, Excerpta Medica, Amsterdam, 1981.
Veronesi, R., Bizzini, B., Focaccia, R., Coscina, A. L., Mazza, C. C., Focaccia, M. T., Carraro, F., and Honningman, M. N., Naturally acquired antibodies to tetanus toxin in humans and animals from the Galapagos Islands, J. Infect. Dis. 147:308–311 1983).
Wang, A. S., Burns, G. F., Kronborg, I. J., and Mackey, I. R., Detection of antibodies to tetanus toxoid: Comparison of a direct haemagglutination method with a radioimmunoassay, J. Clin. Pathol. 35:1138–1141 (1982).
Weinstein, L., Tetanus, N. Engl. J. Med. 289:1293–1296. (1973).
Weiss, B. P., Strassburg, M. A., and Feeley, J. C., Tetanus and diphtheria immunity in an elderly population in Los Angeles County, Am. J. Public Health 73:802–804 (1983).
Wellhoner, J. J., Tetanus neurotoxin, Rev. Physiol. Biochem. Pharmacol. 93:1–68 (1982).
White, W. G., Barnes, G. M., Barker, E., Gall, D., Knight, P., Griffith, A.H., Morris-Owen, R. M., and Smith, J. W., Reactions to tetanus toxoid, J. Hyg. 71:283–297 (1973).
Williams, J. J., and Ellingson, H. V., Field trial of commercially-prepared diphtheria-tetanus toxoid: Immunization reactions among recruits, Unpublished report to the Armed Forces Epidemiologic Board, 1954.
Willis, A. T., Clostridium: The spore-bearing anaerobes, in: Topley and Wilson’s Principles ofBacteriology, Virology and Immunity, Volume 2 (G. Wilson, A. Miles, and M. T. Parker, eds.), pp. 442–475, Williams & Wilkins, Baltimore, 1983.
Winsnes, R., and Christiansen, G., Quantification of tetanus antitoxin in human sera. II. Comparison of counterimmunoelectrophoresis and passive haemagglutination with toxin neutralization in mice, Acta Pathol. Microbiol. Scand. Sec. B 87:197–200 (1979).
Wise, D. L., Trantolo, J., Marino, R. T., and Kitchell, J. P., Opportunities and challenges in the design of implantable biodegradable polymeric systems for the delivery of antimicrobial agents and vaccines, Adv. Drug Delivery Rev. 1:19–30 (1987).
Wolters, K. L., and Dehmel, H., Abschliessende Untersuchungen über die tetanus prophylaxe durch active immunisierung, Z. Hyg. 124:326–332 (1942).
World Health Organization, Immunization Policies in Europe, Report on a Who meeting, Karlovy Vary, Czechoslovakia, World Health Organization Icp/Epi 001 m01, 1430G, 1986 PS4.
Wright, G. P., The neurotoxins of Clostridium botulinum and Clostridium tetani, Pharmacol. Rev. 7:413–456 (1955).
Zacks, S. I., and Shef, M. F., Tetanus toxin: Fine structure, localization of binding sites in striated muscle, Science 159:643–644 (1968).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Orenstein, W.A., Wassilak, S.G.F. (1991). Tetanus. In: Evans, A.S., Brachman, P.S. (eds) Bacterial Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1211-7_34
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1211-7_34
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1213-1
Online ISBN: 978-1-4757-1211-7
eBook Packages: Springer Book Archive